
Alert: Rating Upgrade (3/18/24)-Cardiff Oncology Inc (NASDAQ: CRDF).
Stock Rating Upgrade The Value Trend Rating for Cardiff Oncology Inc (NASDAQ: CRDF) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]